Search results
Results from the WOW.Com Content Network
He was accompanied by the head of the Royal Family medical service, Juan Martínez, and by the Vice-councillor for Public Health and COVID-19 Plan of the Community of Madrid, Antonio Zapatero. Regarding the vaccine brand, although it was not officially communicated, it is known that only Janssen vaccines were given that day.
On 13 March 2020 the Government of the Community of Madrid decreed the shutting down of bars, restaurants and "non-alimentary" shops (only allowing the opening of supermarkets and pharmacies). [6] On 14 March the country-wide state of alarm for an initial period of 15 days was declared in accordance with Article 116.2 of the Spanish constitution .
The COVID-19 pandemic in Spain has resulted in 13,980,340 [1] confirmed cases of COVID-19 and 121,852 [1] deaths.. The virus was first confirmed to have spread to Spain on 31 January 2020, when a German tourist tested positive for SARS-CoV-2 in La Gomera, Canary Islands. [2]
The area has the highest incidence rate of COVID-19 in Spain, with 746.2 cases per 100,000 inhabitants, according to El País. Madrid residents at ‘serious risk’ without tougher coronavirus ...
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received the shot(s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
Germany has extended a partial travel warning for Spain to the capital of Madrid and the Basque region due to the COVID-19 pandemic, the foreign ministry said on Tuesday. The foreign ministry said ...
Spanish airport operator Aena said on Tuesday it would close most terminals at Madrid and Barcelona's main airports after air traffic plummeted due to restrictions imposed to curb the spread of ...
All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...